Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Experimental Hematology is Scopus-indexed (Q2, CiteScore 4), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Elsevier Inc..
Checked against the index lists dated .
ISSN 0301-472XVerify ISSN ↗1873-2399Verify ISSN ↗
Publisher: Elsevier Inc.
Cost to publish: About US$3,250 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Hematology | 60 / 151 | 60th | Q2 |
| Genetics | 191 / 357 | 46th | Q3 |
| Molecular Biology | 273 / 414 | 34th | Q3 |
| Cancer Research | 159 / 233 | 31st | Q3 |
| Cell Biology | 209 / 289 | 27th | Q3 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1973–present, best quartile Q2, CiteScore 4.
Experimental Hematology is Q2 in Hematology (rank 60 of 151), Q3 in Genetics (rank 191 of 357) and Q3 in Molecular Biology (rank 273 of 414), by CiteScore 2025. It is ranked in 5 subject areas in all.
Experimental Hematology is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 4, which places it in quartile Q2 at the 60th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.958, quartile Q2, with an H-index of 133.
The publisher lists an article processing charge of about US$3,250 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Experimental Hematology is published by Elsevier Inc. Its print ISSN is 0301-472X and its online ISSN is 1873-2399.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Experimental Hematology has an h-index of 141 and a 2-year mean of 0.83 citations per paper (OpenAlex). Its Scopus CiteScore is 4, quartile Q2. On 2-year citations it ranks #99 of 148 Scopus journals in Hematology.
Experimental Hematology published 413 papers in 2025; its busiest recent year was 2017 with 436. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 91 research articles (2025–2026), authors are most often from United States (27.2%), Japan (13.4%) and China (11.4%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.